...
首页> 外文期刊>Archives of Pathology & Laboratory Medicine >Cytologic Malignancy Versus Benignancy: How Useful Are the 'Newer' Markers in Body Fluid Cytology?
【24h】

Cytologic Malignancy Versus Benignancy: How Useful Are the 'Newer' Markers in Body Fluid Cytology?

机译:细胞学恶性与良性:体液细胞学中“较新的”标记有多有用?

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Differentiating reactive effusion, malignant mesothelioma, and metastatic adenocarcinoma in body cavity fluids can be challenging. Interpreting immunohistochemical markers in cell block preparations can be difficult because of nonspecific staining, focal staining, or poor staining quality. We selected a panel of conventional and newer markers to assess their utility in evaluating effusions. OBJECTIVE: To evaluate the efficacy of 5 immunohistochemical markers in the differential diagnosis of reactive mesothelial proliferation, malignant mesothelioma, and metastatic adenocarcinoma in body cavity fluids. DESIGN: A total of 72 formalin-fixed, paraffin-embedded cell block specimens from pleural and peritoneal effusions, including 5 mesotheliomas, 48 adenocarcinomas, and 19 benign effusions were stained with antibodies against calretinin, D2-40, XIAP, MOC-31, and WT1. RESULTS: All benign effusions and mesotheliomas demonstrated diffuse membranous staining with D2-40. All mesotheliomas displayed calretinin positivity, whereas only 58% of benign effusions stained focally with calretinin. MOC-31 was positive in all cases of adenocarcinoma, whereas all benign effusions and mesotheliomas were negative. All cases of the metastatic adenocarcinoma were negative for calretinin and D2-40. However, background reactive mesothelial cells were positive for calretinin and D2-40. Overall, D2-40 highlighted more mesothelial cells than calretinin. WT1 was positive in 50% of benign effusions, 60% of mesotheliomas, and 27% of adenocarcinomas. XIAP stained most mesotheliomas (80%), some adenocarcinomas (51%), and rare benign effusions (11%). CONCLUSIONS: MOC-31 and D2-40 were very sensitive and specific markers of epithelial and mesothelial cells, respectively. Compared with calretinin, D2-40 was a more sensitive marker of mesothelial cells. WT1 proved to be nonspecific. XIAP was not a sensitive marker for malignancy and had a limited value in cytology. We recommend using a panel to include MOC-31 and D2-40 to improve diagnostic accuracy in body cavity effusions.
机译:背景:区分体液中的反应性积液,恶性间皮瘤和转移性腺癌可能具有挑战性。由于非特异性染色,局灶性染色或差的染色质量,难以解释细胞块制剂中的免疫组织化学标记物。我们选择了一组常规和较新的标记来评估其在评估积液中的效用。目的:评价5种免疫组化标志物在体液中反应性间皮增生,恶性间皮瘤和转移性腺癌的鉴别诊断中的作用。设计:对72份福尔马林固定的,石蜡包埋的细胞块标本进行了胸膜和腹膜积液标本,包括5个间皮瘤,48例腺癌和19例良性积液,用抗钙黄蛋白,D2-40,XIAP,MOC-31,和WT1。结果:所有良性积液和间皮瘤均表现为D2-40弥漫性膜染色。所有间皮瘤均显示钙调蛋白阳性,而良性积液仅58%局部被钙调蛋白染色。在所有腺癌病例中,MOC-31均为阳性,而所有良性积液和间皮瘤均为阴性。所有转移性腺癌病例的钙调蛋白和D2-40均为阴性。但是,背景反应性间皮细胞钙调蛋白和D2-40呈阳性。总体而言,D2-40突出的间皮细胞多于钙调蛋白。 WT1在50%的良性积液,60%的间皮瘤和27%的腺癌中呈阳性。 XIAP对大多数间皮瘤(80%),一些腺癌(51%)和罕见的良性积液(11%)染色。结论:MOC-31和D2-40分别是上皮细胞和间皮细胞的非常敏感的特异性标志物。与钙卫蛋白相比,D2-40是间皮细胞更敏感的标记。 WT1被证明是非特异性的。 XIAP不是恶性肿瘤的敏感标志物,在细胞学上的价值有限。我们建议使用包含MOC-31和D2-40的面板,以提高体腔积液的诊断准确性。

著录项

  • 来源
    《Archives of Pathology & Laboratory Medicine》 |2008年第1期|p.23-27|共5页
  • 作者单位

    Virganeyce Lyons-Boudreaux, MD, Dina R. Mody, MD, Jim Zhai, MD, Donna Coffey, MDAccepted for publication August 10, 2007.From the Departments of Pathology and Laboratory Medicine, The Methodist Hospital (Dr Lyons-Boudreaux) and Pathology and Laboratory Medicine, Weill Medical College of Cornell University and The Methodist Hospital (Drs Mody, Zhai, and Coffey), Houston, Tex. Dr Lyons-Boudreaux is now in private practice in San Antonio, Tex.The authors have no relevant financial interest in the products or companies described in this article.The abstract of this article was presented in poster form at the annual meeting of the College of American Pathologists, San Diego, Calif, September 10, 2006. It was the recipient of the fourth place award for resident/fellow submissions.Reprints: Dina R. Mody, MD, Weill Medical College of Cornell University, The Methodist Hospital, Department of Pathology, M227, Houston, TX 77030 (e-mail: dmody@tmh.tmc.edu).,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号